» Articles » PMID: 37889078

The Three-dimensional Structure of the EBV Genome Plays a Crucial Role in Regulating Viral Gene Expression in EBVaGC

Overview
Specialty Biochemistry
Date 2023 Oct 27
PMID 37889078
Authors
Affiliations
Soon will be listed here.
Abstract

Epstein-Barr virus (EBV) establishes lifelong asymptomatic infection by replication of its chromatinized episomes with the host genome. EBV exhibits different latency-associated transcriptional repertoires, each with distinct three-dimensional structures. CTCF, Cohesin and PARP1 are involved in maintaining viral latency and establishing episome architecture. Epstein-Barr virus-associated gastric cancer (EBVaGC) represents 1.3-30.9% of all gastric cancers globally. EBV-positive gastric cancers exhibit an intermediate viral transcription profile known as 'Latency II', expressing specific viral genes and noncoding RNAs. In this study, we investigated the impact of PARP1 inhibition on CTCF/Cohesin binding in Type II latency. We observed destabilization of the binding of both factors, leading to a disrupted three-dimensional architecture of the episomes and an altered viral gene expression. Despite sharing the same CTCF binding profile, Type I, II and III latencies exhibit different 3D structures that correlate with variations in viral gene expression. Additionally, our analysis of H3K27ac-enriched interactions revealed differences between Type II latency episomes and a link to cellular transformation through docking of the EBV genome at specific sites of the Human genome, thus promoting oncogene expression. Overall, this work provides insights into the role of PARP1 in maintaining active latency and novel mechanisms of EBV-induced cellular transformation.

Citing Articles

Histone Variant H2A.Z Cooperates with EBNA1 to Maintain Epstein-Barr Virus Latent Epigenome.

Castro-Munoz J, Maestri D, Yoon L, Karisetty B, Tempera I, Lieberman P bioRxiv. 2025; .

PMID: 39975074 PMC: 11838259. DOI: 10.1101/2025.01.28.635203.


The HSV-1 encoded CCCTC-binding factor, CTRL2, impacts the nature of viral chromatin during HSV-1 lytic infection.

Singh P, Zhu L, Shipley M, Ye Z, Neumann D PLoS Pathog. 2024; 20(10):e1012621.

PMID: 39374265 PMC: 11486355. DOI: 10.1371/journal.ppat.1012621.


The DNA loop release factor WAPL suppresses Epstein-Barr virus latent membrane protein expression to maintain the highly restricted latency I program.

Murray-Nerger L, Maestri D, Liu X, Li Z, Auld N, Tempera I PLoS Pathog. 2024; 20(9):e1012525.

PMID: 39241017 PMC: 11410233. DOI: 10.1371/journal.ppat.1012525.

References
1.
Lareau C, Aryee M . hichipper: a preprocessing pipeline for calling DNA loops from HiChIP data. Nat Methods. 2018; 15(3):155-156. PMC: 10572103. DOI: 10.1038/nmeth.4583. View

2.
Price A, Luftig M . To be or not IIb: a multi-step process for Epstein-Barr virus latency establishment and consequences for B cell tumorigenesis. PLoS Pathog. 2015; 11(3):e1004656. PMC: 4366242. DOI: 10.1371/journal.ppat.1004656. View

3.
Mattiussi S, Tempera I, Matusali G, Mearini G, Lenti L, Fratarcangeli S . Inhibition of Poly(ADP-ribose)polymerase impairs Epstein Barr Virus lytic cycle progression. Infect Agent Cancer. 2007; 2:18. PMC: 2170434. DOI: 10.1186/1750-9378-2-18. View

4.
Preston-Alp S, Caruso L, Su C, Keith K, Soldan S, Maestri D . Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer. mBio. 2023; 14(5):e0039623. PMC: 10653948. DOI: 10.1128/mbio.00396-23. View

5.
Caruso L, Maestri D, Tempera I . Three-Dimensional Chromatin Structure of the EBV Genome: A Crucial Factor in Viral Infection. Viruses. 2023; 15(5). PMC: 10222312. DOI: 10.3390/v15051088. View